Gulácsi L - Search Results

1

Dermatology Life Quality Index (DLQI) score bands are applicable to DLQI-Relevant (DLQI-R) scoring.

Rencz F, Gergely LH, Wikonkál N, Gáspár K, Péntek M, Gulácsi L, Tamási B, Poór AK, Kinyó Á, Bali G, Hidvégi B, Sárdy M, Hajdu K, Szegedi A, Remenyik É, Bata-Csörgő Z, Holló P, Baji P, Brodszky V. Rencz F, et al. Among authors: gulacsi l. J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e484-e486. doi: 10.1111/jdv.16398. Epub 2020 May 12. J Eur Acad Dermatol Venereol. 2020. PMID: 32243628 No abstract available.

2

[The role of biological drugs in the treatment of psoriasis, results from 9 randomized placebo-controlled trials].

Kemény L, Brodszky V, Kárpáti K, Gulácsi L. Kemény L, et al. Among authors: gulacsi l. Orv Hetil. 2006 May 28;147(21):981-90. Orv Hetil. 2006. PMID: 16812973 Review. Hungarian.

3

[The role of biologic agents in the therapy of ankylosing spondylitis].

Géher P, Nagy MB, Péntek M, Tóth E, Brodszky V, Gulácsi L. Géher P, et al. Among authors: gulacsi l. Orv Hetil. 2006 Jul 2;147(26):1203-13. Orv Hetil. 2006. PMID: 16898082 Review. Hungarian.

4

Epidemiology of osteoporosis related fractures in Hungary from the nationwide health insurance database, 1999-2003.

Péntek M, Horváth C, Boncz I, Falusi Z, Tóth E, Sebestyén A, Májer I, Brodszky V, Gulácsi L. Péntek M, et al. Among authors: gulacsi l. Osteoporos Int. 2008 Feb;19(2):243-9. doi: 10.1007/s00198-007-0453-6. Epub 2007 Aug 16. Osteoporos Int. 2008. PMID: 17701364

5

[Rituximab in patients with rheumatoid arthritis: systematic review].

Brodszky V, Czirják L, Géher P, Hodinka L, Kárpáti K, Péntek M, Poór G, Szekanecz Z, Gulácsi L. Brodszky V, et al. Among authors: gulacsi l. Orv Hetil. 2007 Oct 7;148(40):1883-93. doi: 10.1556/OH.2007.28080. Orv Hetil. 2007. PMID: 17905683 Review. Hungarian.

6

[Impact of disease progression on health status, quality of life and costs in rheumatoid arthritis in Hungary].

Péntek M, Szekanecz Z, Czirják L, Poór G, Rojkovich B, Polgár A, Genti G, Kiss CG, Sándor Z, Májer I, Brodszky V, Gulácsi L. Péntek M, et al. Among authors: gulacsi l. Orv Hetil. 2008 Apr 20;149(16):733-41. doi: 10.1556/OH.2008.28294. Orv Hetil. 2008. PMID: 18426720 Hungarian.

7

Efficacy of adalimumab, etanercept, and infliximab in psoriatic arthritis based on ACR50 response after 24 weeks of treatment.

Brodszky V, Pentek M, Gulacsi L. Brodszky V, et al. Among authors: gulacsi l. Scand J Rheumatol. 2008 Sep-Oct;37(5):399-400. doi: 10.1080/03009740802004966. Scand J Rheumatol. 2008. PMID: 18821278 No abstract available.

8

Disease burden of psoriatic arthritis compared to rheumatoid arthritis, Hungarian experiment.

Brodszky V, Bálint P, Géher P, Hodinka L, Horváth G, Koó É, Péntek M, Polgár A, Seszták M, Szántó S, Ujfalussy I, Gulácsi L. Brodszky V, et al. Among authors: gulacsi l. Rheumatol Int. 2009 Dec;30(2):199-205. doi: 10.1007/s00296-009-0936-1. Rheumatol Int. 2009. PMID: 19381635

9

History of health technology assessment in Hungary.

Gulácsi L, Brodszky V, Péntek M, Varga S, Vas G, Boncz I. Gulácsi L, et al. Int J Technol Assess Health Care. 2009 Jul;25 Suppl 1:120-6. doi: 10.1017/S0266462309090527. Epub 2009 Jun 8. Int J Technol Assess Health Care. 2009. PMID: 19500441

10

The disease burden of colorectal cancer in Hungary.

Boncz I, Brodszky V, Péntek M, Agoston I, Nagy Z, Kárpáti K, Kriszbacher I, Fuszek P, Gulácsi L. Boncz I, et al. Among authors: gulacsi l. Eur J Health Econ. 2010 Jan;10 Suppl 1:S35-40. doi: 10.1007/s10198-009-0192-z. Eur J Health Econ. 2010. PMID: 20012135

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters